...
IndustrialSage Logo
  • Shows
    • Practitioners Unplugged
    • Industry Next
    • From the Floor: Trade Shows
    • American Makers
    • Brewed In America
    • Industries of the Future, Presented by Schneider Electric
    • Bright Ideas by Acuity Brands
    • Executive Series
    • Making Connections Presented by Brennan Industries
    • Sales & Marketing Insights
    • Sales & Marketing How To
    • Webinars
    • Create Custom Content
    • Sponsor A New Show!
  • Industrial and Manufacturing News
    • Industry News
    • Submit a Story
  • Articles
  • Members
    • Login
    • Member Dashboard
    • Add Agency to Directory
    • Profile
    • Create Account
    • Press Submission
  • Services
  • About
    • About Our Team
    • About IndustrialSage
    • About the Studio
    • Reviews
    • Agency Directory
    • Our Sponsors
      • Optimum Productions
    • Careers
    • Subscribe
  • Contact
  • Shows
    • Practitioners Unplugged
    • Industry Next
    • From the Floor: Trade Shows
    • American Makers
    • Brewed In America
    • Industries of the Future, Presented by Schneider Electric
    • Bright Ideas by Acuity Brands
    • Executive Series
    • Making Connections Presented by Brennan Industries
    • Sales & Marketing Insights
    • Sales & Marketing How To
    • Webinars
    • Create Custom Content
    • Sponsor A New Show!
  • Industrial and Manufacturing News
    • Industry News
    • Submit a Story
  • Articles
  • Members
    • Login
    • Member Dashboard
    • Add Agency to Directory
    • Profile
    • Create Account
    • Press Submission
  • Services
  • About
    • About Our Team
    • About IndustrialSage
    • About the Studio
    • Reviews
    • Agency Directory
    • Our Sponsors
      • Optimum Productions
    • Careers
    • Subscribe
  • Contact
Home Blog
Gowned technician in mask and gloves writing on a clipboard beside sample vials

Audit-Ready All Year: 5 Validation Practices Every Life Sciences Manufacturer Should Revisit

by Rhea Singh
October 22, 2026
in Blog
Reading Time: 5 mins read
1
SHARES
Share on LinkedIn Share on FacebookShare on TwitterEmail this Article

For life sciences manufacturers, audit readiness is about more than having the right documentation available when an inspector arrives. It requires confidence that the systems supporting product quality, manufacturing, and regulatory compliance are operating as intended, and that the evidence exists to demonstrate it.

Enterprise resource planning systems play a critical role in that responsibility. From inventory and lot traceability to production records and quality processes, ERP platforms often support workflows that directly affect product quality and patient safety.

Yet as software evolves, configurations change, and new releases become available, maintaining that confidence can become increasingly complex.

The challenge isn’t simply preparing for the next audit. It’s maintaining a state of control between audits.

For life sciences organizations operating in regulated environments, five practices deserve particular attention.

1. Treat Audit Readiness as an Ongoing Process, Not a Deadline

When audit preparation begins only after an inspection is scheduled, teams may find themselves scrambling to locate validation protocols, confirm approvals, reconcile documentation, or explain changes made months earlier.

This reactive approach puts unnecessary pressure on quality, IT, and operations teams.

A stronger approach integrates audit readiness into everyday processes. Validation documentation, change control records, risk assessments, training records, and approval histories should be maintained as work occurs, not reconstructed later.

What to revisit:

  • Are validation records current and accessible?
  • Can your team demonstrate who approved a change, when it occurred, and why it was necessary?
  • Are deviations and corrective actions documented, investigated, and resolved appropriately?
  • Can you trace system requirements to the evidence demonstrating that controls work as intended?

Maintaining this discipline makes inspections more manageable and helps organizations identify documentation gaps before they become larger problems.

2. Strengthen Data Integrity Across Your Systems

Data integrity is fundamental to regulated manufacturing. Information must be reliable, accurate, complete, and appropriately controlled throughout its lifecycle.

Business systems may support records related to material traceability, inventory movements, manufacturing activities, quality decisions, and product history. If information is incomplete, improperly modified, or difficult to trace, the consequences can extend beyond an IT issue.

Organizations should understand how data moves across their systems, where critical records are created and maintained, and which controls protect that information.

What to revisit:

  • User access permissions and segregation of duties
  • Audit trails and the ability to investigate changes to critical records
  • Data transfers between enterprise systems, quality management platforms, and manufacturing applications
  • Backup, recovery, and retention practices
  • Procedures for reviewing and investigating data discrepancies

Data integrity cannot be achieved through software alone. It depends on appropriate system controls, documented procedures, trained personnel, and consistent oversight.

The goal is to ensure that critical information remains trustworthy and that the organization can demonstrate how its integrity is protected.

3. Reassess Validation When Software Changes

Software environments are not static. Vendors release updates, organizations modify configurations, integrations evolve, and business processes change.

Each change raises an important question: Does the existing validation evidence still demonstrate that the system performs as intended for its intended use?

Without a defined change control process, organizations risk either overlooking changes that require assessment or repeating extensive validation work without adequately considering the actual risk.

A risk-based approach begins with understanding what changed, which functions may be affected, and the potential impact on product quality, patient safety, and regulated processes.

Not every software change presents the same level of risk, and validation activities should be appropriately scoped to reflect that difference.

What to revisit:

  • Formal assessment and approval of software changes
  • Identification of affected workflows, configurations, integrations, and reports
  • Risk-based decisions about the testing and evidence required
  • Review of vendor-provided testing evidence where appropriate
  • Documentation of results, deviations, and final approvals

The FDA’s Computer Software Assurance (CSA) guidance supports a risk-based approach to establishing confidence in software used in medical device production and quality management systems.

For manufacturers, this creates an opportunity to reconsider whether validation activities are focused on the functions and risks that matter most rather than applying the same testing approach to every change.

The objective is not to eliminate validation. It is to make validation more purposeful, defensible, and proportionate to risk.

4. Establish Clear Ownership Between Quality, IT, and Operations

Audit readiness is not solely the responsibility of the quality department.

IT teams understand system architecture, access controls, integrations, and technical changes. Quality teams bring expertise in regulated processes, risk assessment, and compliance requirements. Operations teams understand how systems support actual manufacturing activities.

When these groups work in silos, important gaps can emerge. A technical update may be completed without adequate consideration of its impact on a quality-critical process. Alternatively, quality teams may lack the technical information needed to assess a change effectively.

Clear ownership and communication help bridge that gap.

What to revisit:

  • Defined responsibilities for validation planning, execution, review, and approval
  • Documented procedures for communicating proposed system changes
  • Clear escalation paths for deviations and potential compliance issues
  • Appropriate involvement of process owners in risk assessments
  • Periodic reviews of system performance, controls, and outstanding issues

A cross-functional approach helps ensure that validation decisions reflect both the technical behavior of the software and its impact on regulated business processes.

It also reduces the likelihood that critical decisions depend on informal communication or individual knowledge that may not be documented.

5. Reduce Repetitive Validation Work Without Compromising Compliance

One of the most persistent challenges in regulated environments is the amount of work required to maintain validation evidence as software evolves.

Organizations may repeatedly recreate documentation, execute similar tests, and assemble evidence for standard vendor functionality that has already been assessed elsewhere.

This can consume valuable resources that might otherwise be directed toward higher-risk processes, data integrity improvements, and continuous quality improvement.

The opportunity is to distinguish between baseline software evidence and the validation activities specific to an organization’s own environment.

Pre-built validation evidence can provide a foundation for assessing standard software functionality. However, each manufacturer must still determine how that evidence applies to its configurations, intended use, products, processes, and risk profile.

What to revisit:

  • Which validation activities are repeated for each software release?
  • Can relevant vendor or baseline testing evidence be leveraged?
  • Which configurations, integrations, and workflows require organization-specific assessment?
  • Are testing activities appropriately prioritized according to risk?
  • Can documentation templates and standardized processes reduce administrative effort?

A more structured validation model can make a meaningful difference.

Build a More Sustainable Approach to Audit Readiness

Audit readiness is not a single project to complete before an inspection. It is the result of consistent practices that protect data integrity, maintain system control, document changes, and establish confidence in validated systems over time.

For life sciences manufacturers, the most effective approach combines sound quality processes, cross-functional accountability, risk-based validation, and reliable evidence.

As software platforms continue to evolve, organizations should regularly evaluate whether their validation practices are keeping pace, and whether their teams are spending time on activities that genuinely improve compliance and reduce risk.

Note: Validation requirements depend on applicable regulations, system intended use, and the organization’s quality system. Baseline validation evidence does not replace customer-specific risk assessment, testing, documentation, or quality approval.

Rhea Singh, Director of Marketing at Strategic Information Group

Author: Rhea Singh

Rhea Singh is the Director of Marketing at Strategic Information Group, where she focuses on how regulated and compliance-driven manufacturers, including those in the defense, aerospace, and life sciences supply chains, approach ERP modernization, digital transformation, and AI adoption. With nearly a decade of enterprise technology marketing experience across leading ERP platforms including QAD, NetSuite, Infor, and Acumatica, she brings a broad perspective on the evolving needs of modern manufacturers. Her work explores the operational, technological, and architectural shifts reshaping how industrial companies improve agility, maintain compliance, leverage AI, and stay competitive and contract-eligible.

Tags: compliancedata integrityFDAlife sciencesquality managementvalidation